Back
Compass Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
CMPX
Compass Therapeutics, Inc.
Last Price:
$5.44
Seasonality Move:
9.93%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CMPX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Compass Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.33 | Buy |
| 20-day SMA: | 5.34 | Buy |
| 50-day SMA: | 5.84 | Sell |
| 200-day SMA: | 4.42 | Buy |
| 8-day EMA: | 5.34 | Buy |
| 20-day EMA: | 5.41 | Buy |
| 50-day EMA: | 5.54 | Sell |
| 200-day EMA: | 4.6 | Buy |
Compass Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | 2251638 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.22 - 5.58) | Buy |
| Bollinger Bands (100): | (4.97 - 6.05) | Sell |
Compass Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Compass Therapeutics, Inc. Stock
Is Compass Therapeutics, Inc. Stock a Buy?
-
Compass Therapeutics, Inc. share price is 5.45 while CMPX 8-day simple moving average is 5.33, which is a Buy signal.
-
The stock price of CMPX is 5.45 while Compass Therapeutics, Inc. 20-day SMA is 5.34, which makes it a Buy.
-
Compass Therapeutics, Inc. 50-day simple moving average is 5.84 while CMPX share price is 5.45, making it a Sell technically.
-
CMPX stock price is 5.45 and Compass Therapeutics, Inc. 200-day simple moving average is 4.42, creating a Buy signal.
CMPX Technical Analysis vs Fundamental Analysis
Sell
48
Compass Therapeutics, Inc. (CMPX)
is a Sell
Is Compass Therapeutics, Inc. a Buy or a Sell?
-
Compass Therapeutics, Inc. stock is rated a SellThe current Compass Therapeutics, Inc. [CMPX] share price is $5.45. The Score for CMPX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Compass Therapeutics, Inc. Stock Info
Market Cap:
983.3M
Price in USD:
5.45
Share Volume:
3.2M
Compass Therapeutics, Inc. 52-Week Range
52-Week High:
6.88
52-Week Low:
1.40
Sell
48
Compass Therapeutics, Inc. (CMPX)
is a Sell
Compass Therapeutics, Inc. Share Price Forecast
-
What is the Compass Therapeutics, Inc. stock price today?The Compass Therapeutics, Inc. stock price is 5.45 USD today.
-
Will CMPX stock go up or go down?Compass Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Compass Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Compass Therapeutics, Inc. is overvalued.
Is Compass Therapeutics, Inc. Stock a Buy?
-
Compass Therapeutics, Inc. share price is 5.45 while CMPX 8-day exponential moving average is 5.34, which is a Buy signal.
-
The stock price of CMPX is 5.45 while Compass Therapeutics, Inc. 20-day EMA is 5.41, which makes it a Buy.
-
Compass Therapeutics, Inc. 50-day exponential moving average is 5.54 while CMPX share price is 5.45, making it a Sell technically.
-
CMPX stock price is 5.45 and Compass Therapeutics, Inc. 200-day simple moving average is 4.60, creating a Buy signal.
Fundamental Analysis of Compass Therapeutics, Inc.
Is Compass Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.01 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Compass Therapeutics, Inc.
Should I short Compass Therapeutics, Inc. stock?
-
CMPX Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Compass Therapeutics, Inc. is a Sell
-
Compass Therapeutics, Inc. Relative Strength Index (RSI) is 49.51, which suggest Compass Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Compass Therapeutics, Inc. is (5.22 - 5.58), which suggest Compass Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Compass Therapeutics, Inc. is (4.97 - 6.05), which suggest Compass Therapeutics, Inc. is a Sell
* Compass Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.